Biochips enable the accurate, rapid, and high-throughput detection of DNA, RNA, polypeptides, proteins, cells, tissues, and other biological components, with great advantages in disease screening and early diagnosis.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Siemens Healthineers (Erlangen, Germany) has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marki

December 22nd 2018 was Winter Solstice. Ancient Chinese believed that Yangqi (positive or muscular things) will become stronger and stronger after this day and a new life cycle begins, so it should be celebrated as an auspicious day. It was

Sysmex and MolecularMD have signed a non-exclusive collaboration agreement focused on the development and commercialization of companion diagnostics for precision medicine. As part of the collaboration, the firms said they will integrate the

Greiner Bio One International (Kremsmnster, Obersterreich, Austria) has launched the innovative VACUETTE SAFELINK tube holder with male luer lock that facilitates quick and easy blood collection. The tube offers simple handling and can be us

The global point of care (POC) urinalysis market is projected to grow at a CAGR of more than 3% over the 2018-2022 period, driven mainly by the rising prevalence of nephropathic disorders and urinary tract infections (UTIs) which is generati

Danaher today initiated its earning outlook for 2019, saying EPS is anticipated to be in the range of $4.02 to $4.12. On a non-GAAP basis, EPS is expected to be in the range of $4.75 to $4.85, which assumes non-GAAP core revenue growth of ab

The New York State Department of Health has approved a whole-genome and transcriptome sequencing oncology test developed by the New York Genome Center for clinical testing. According to NYGC, it is the first whole-genome cancer test to rece

Agilent technologies has announced a new expansion of its Little Island facility in cork, Ireland.The facility park will be dedicated to developing advanced technologies for real-time analysis of living cells. The expanded facility includes

Mesa Biotech recently said that the US Food and Drug Administration has cleared and CLIA-waived the companys Accula RSV respiratory syncytial virus test for diagnostic use in both children and adults. According to the San Diego-based firm,

Novacyt announced recently that its molecular testing division, Primerdesign, has inked an exclusive supply agreement with Genesis Diagnostics. Primerdesign will develop and supply 384-well plate molecular assay panels in the areas of respi